---
title: 'Post-diagnostic multivitamin supplement use and colorectal cancer survival:
  A prospective cohort study'
date: '2024-02-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38319287/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240206170607&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Use of multivitamin supplements at a moderate dose after
  a diagnosis of nonmetastatic CRC is associated with lower CRC-specific and overall
  mortality, whereas a high dose (≥10 tablets/week) use is associated with higher
  CRC-specific ...'
disable_comments: true
---
CONCLUSIONS: Use of multivitamin supplements at a moderate dose after a diagnosis of nonmetastatic CRC is associated with lower CRC-specific and overall mortality, whereas a high dose (≥10 tablets/week) use is associated with higher CRC-specific ...